Skip to main content

Table 1 Clinical and laboratory characteristics of IBD patients

From: Hidden musculoskeletal involvement in inflammatory bowel disease: a multicenter ultrasound study

Crohn’s disease/Ulcerative colitis 43/33 patients
Age 39.93 ± 14.02 years
BMI 23.36 ± 4.13 kg/m2
Disease duration 7.91 ± 6.18 years
Active/inactive bowel disease 51.3 %/48.7 %
Disease flares 2.53 ± 1.97
ASCA positive 25 % (CD)
pANCA positive 18.4 % (17 % UC + 1.4 % CD)
HLA B 27 positive 2.6 %
CRP 0.69 ± 0.96 mg/dL
ESR 14.52 ± 11.48 mm/h
Medications  
- Corticosteroids 19.7 %
- 5 ASA 42.1 %
- Anti-TNFα 32.9 %
- Azathioprine 28.9 %
- Cyclosporine 1.3 %